From May 10 to 13, 2026, the 18th International Conference on Cochlear Implants and Other Implantable Technologies (CI 2026) was held on an international stage rich in academic atmosphere. As a premier global event in the field of hearing implants, CI 2026 brought together leading otologists, audiologists, engineers, and industry leaders from around the world. Nurotron made a strong appearance with its latest research achievements and innovative products, showcasing the tangible strength of Chinese neuro-electronic technology to the global community.
Exhibition Scene: From “Heard About It” to “Seeing It in Person” – International Experts Deeply Impressed
Throughout the conference, the Nurotron booth remained bustling with visitors, becoming one of the most popular spots at the venue. Physicians, experts, and audiologists from various countries stopped by, showing strong interest in the Nurotron cochlear implant system.
Many visitors admitted that they had long been curious about Nurotron, a brand from China, but had previously been hesitant due to limited trust in Chinese-made products. However, when they personally handled the elegantly designed implant and lightweight external processor, their attitudes shifted noticeably – whether in terms of craftsmanship, technical specifications, or wearing experience, Nurotron products were recognized as reaching world-class standards. Several experts expressed on the spot that they look forward to Nurotron entering their home markets as soon as possible to benefit more local people with hearing loss.
These warm exchanges marked how Nurotron, through its proven quality, has successfully earned the recognition and respect of the international professional community.
Multiple Oral Presentations Receive High Praise, Highlighting Academic Depth
In addition to product demonstrations, Nurotron’s research collaborations with institutions such as the Chinese PLA General Hospital, the First Affiliated Hospital of Anhui Medical University, the Second Qilu Hospital of Shandong University, the First Affiliated Hospital of Zhengzhou University, and the Renmin Hospital of Wuhan University were presented orally at the conference. Nurotron’s CMO, Prof. Yin Li, Chief Medical Officer of the Nurotron Hearing Research Institute, and Clinical Research Specialist Liu Tianyi delivered several high-level oral presentations at the conference, which were met with enthusiastic responses, fully demonstrating Nurotron’s profound experience in the clinical application and research of cochlear implants.
– Long-term efficacy of Chinese domestic cochlear implants: A 15-year in-depth follow-up in post-lingual deafened patients
This 15-year follow-up confirmed that Nurotron cochlear implants provide sustained safety and effectiveness over the long term, with continued improvements in hearing, speech recognition, and quality of life – outcomes that remain stable across time.
– Clinical Outcomes of Unilateral Cochlear Implantation in Children with Hearing Loss and Common Cavity Inner Ear Malformation
Children with common cavity deformity who received Nurotron cochlear implants showed significant progress in hearing and speech within six months after activation, demonstrating the device’s good suitability for this challenging population.
– Exploration of the Effectiveness of Online Remote Programming for Domestic Cochlear Implant Systems
Remote programming for Nurotron cochlear implants was found to be as effective as traditional in-person fitting in improving hearing thresholds and speech recognition, with high patient acceptance – offering a viable option for those with limited mobility or in underserved areas.
– Safety and Effectiveness of the NSP-100A off-the-ear Cochlear Implant Sound Processor
The Nurotron-developed NSP-100A off-the-ear processor enhanced speech recognition in both quiet and noisy environments, received high user satisfaction, and reported no adverse events – reflecting strong safety and effectiveness.
– Clinical Evaluation of AutoNRM (Automatic Neural Response Measurement) for Automatic Cochlear Implant Fitting
Nurotron’s AutoNRM system automatically generates initial fitting maps based on objective neural responses, achieving hearing outcomes, speech perception, and user experience comparable to conventional fitting – proving itself safe, reliable, and capable of significantly improving fitting efficiency.
Taken together, these research findings – spanning special anatomical cases, long-term follow-up, remote services, innovative hardware, and intelligent fitting – comprehensively demonstrate that Nurotron cochlear implants stand the test of time and clinical validation, offering a reliable choice crafted with care for hearing-impaired recipients.
Continuing to Strive on the International Stage, Let the “Voice of China” Resonate Worldwide
As a medical-grade invasive brain computer interface (BCI) leading enterprise, Nurotron has always been committed to making its mark and staying at the forefront of the global hearing arena. CI 2026 was not only a successful showcase and exchange opportunity but also another major milestone in Nurotron’s internationalization strategy.
We sincerely thank the CI 2026 conference for providing this premier academic exchange platform, and we appreciate the attention and recognition from colleagues around the world. Looking ahead, Nurotron will continue to be driven by scientific innovation and guided by clinical needs, actively participating in international conferences and exhibitions, and promoting more high-quality, safe, and effective Chinese-made implantable medical devices to the global market – so that hearing loss knows no borders, and more lives can rediscover the gift of sound.
